Neuren Pharmaceuticals Ltd ASX:NEU:

  • DAYBU RECOMMENDED FOR APPROVAL IN EUROPEAN UNION

  • IF MARKETING AUTHORISATION GRANTED AND LAUNCHED, CO ENTITLED US$35 MILLION FOLLOWING FIRST COMMERCIAL SALE IN EU